{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:28:53Z","timestamp":1747153733772,"version":"3.40.5"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s10072-021-05715-z","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T11:04:43Z","timestamp":1636542283000},"page":"789-790","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Down syndrome: the aggravation of COVID-19 may be partially justified by the expression of TMPRSS2"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0560-0115","authenticated-orcid":false,"given":"Victor Gustavo Oliveira","family":"Evangelho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0860-870X","authenticated-orcid":false,"given":"Murilo Lamim","family":"Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5283-1541","authenticated-orcid":false,"given":"Helena Carla","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0528-0377","authenticated-orcid":false,"given":"Marcia Rodrigues","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,10]]},"reference":[{"key":"5715_CR1","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s10072-021-05091-8","volume":"42","author":"A Emami","year":"2021","unstructured":"Emami A, Javanmardi F, Akbari A, Asadi-Pooya AA (2021) COVID-19 in patients with Down syndrome. Neurol Sci 42:1649\u20131652. https:\/\/doi.org\/10.1007\/s10072-021-05091-8","journal-title":"Neurol Sci"},{"key":"5715_CR2","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","volume":"26","author":"W Sungnak","year":"2020","unstructured":"Sungnak W, Huang N, B\u00e9cavin C et al (2020) SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med 26:681\u2013687. https:\/\/doi.org\/10.1038\/s41591-020-0868-6","journal-title":"Nat Med"},{"key":"5715_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271-280.e8. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"5715_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12987-021-00267-y","volume":"18","author":"C McQuaid","year":"2021","unstructured":"McQuaid C, Brady M, Deane R (2021) SARS-CoV-2: is there neuroinvasion? Fluids Barriers CNS 18:1\u201321. https:\/\/doi.org\/10.1186\/s12987-021-00267-y","journal-title":"Fluids Barriers CNS"},{"key":"5715_CR5","doi-asserted-by":"publisher","first-page":"100769","DOI":"10.1016\/j.eclinm.2021.100769","volume":"33","author":"A H\u00fcls","year":"2021","unstructured":"H\u00fcls A, Costa ACS, Dierssen M et al (2021) Medical vulnerability of individuals with Down syndrome to severe COVID-19-data from the Trisomy 21 Research Society and the UK ISARIC4C survey. EClinicalMedicine 33:100769. https:\/\/doi.org\/10.1016\/j.eclinm.2021.100769","journal-title":"EClinicalMedicine"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05715-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05715-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05715-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T11:16:32Z","timestamp":1643109392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05715-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,10]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["5715"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05715-z","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2021,11,10]]},"assertion":[{"value":"6 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}